Clinical Review

Overtreatment common in high-risk diabetes patients

Author and Disclosure Information

 

AT THE ADA ANNUAL SCIENTIFIC SESSIONS

Dr. Pogach was quick to rebut.

"I think the published results of the ACCORD and ADVANCE studies demonstrate that there’s a very strong association between cardiovascular morbidity and mortality and self-reported hypoglycemia, with adjusted odds ratios of about two and one-half," he explained. "I don’t think those data will ever be beat. We’re never going to have a randomized trial. So, I think the association with adverse outcomes is very clear, although we don’t know if hypoglycemia is the proximate cause or not."

The Department of Veterans Affairs supported the study. Dr. Pogach reported having no financial conflicts of interest.

To earn 0.25 hours AMA PRA Category 1 credit after reading this article, take the post-test here.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Insulin boosted memory in patients with high-risk Alzheimer's allele
Type 2 Diabetes ICYMI
Would patients open wallets for fewer diabetes drug doses?
Type 2 Diabetes ICYMI
Two meals per day better than six in T2DM
Type 2 Diabetes ICYMI
Children of diabetic mothers at greater risk of overweight as young adults
Type 2 Diabetes ICYMI
Pilot study: Vitamin D promising for diabetic pain
Type 2 Diabetes ICYMI
Octogenarians hard hit by insulin adverse events
Type 2 Diabetes ICYMI
Aging-related functional decline boosts diabetes risk
Type 2 Diabetes ICYMI
Add-on dapagliflozin achieves combined weight/HbA1c reduction more often than glipizide
Type 2 Diabetes ICYMI
Novel insulin/GLP-1 combo succeeds in phase III trial
Type 2 Diabetes ICYMI
Osteoprotegerin ups risk of vascular events in type 1 diabetes
Type 2 Diabetes ICYMI